Feedback
Settings

Settings

Goto Application

392,050 results
Offices all Languages Stemming false Single Family Member true Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61K36/00

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1 / 39,205
1.WO/2026/101876METHOD OF ENHANCING THE BIOAVAILABILITY OF BIOACTIVE CHEMICAL COMPOUNDS AND THERAPEUTIC DRUGS, NOVEL BIOAVAILABLE COMPOUNDS, AND METHODS OF USE
WO - 15.05.2026
Int.Class A61K 36/07
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
06Fungi, e.g. yeasts
07Basidiomycota, e.g. Cryptococcus
 Appl.No PCT/US2025/053912 Applicant GEROSYNTH LABORATORIES, INC. Inventor O'DELL, Alisha S.
Methods for chemically modifying bioactive triterpene compounds to increase the bioavailability thereof. The resulting triterpene chemical compounds, having enhanced bioavailability, are useful in pharmaceutical compositions, alone, in combination with, or complexed with therapeutic drugs for the treatment of diseases such as cancers.
2.WO/2026/099182YEAST CELL WALL EXTRACT FOR REDUCING/INHIBITING THE FORMATION OF DENTAL BIOFILM
WO - 15.05.2026
Int.Class A61K 36/064
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
06Fungi, e.g. yeasts
062Ascomycota
064Saccharomycetales, e.g. baker's yeast
 Appl.No PCT/EP2025/081795 Applicant LESAFFRE ET COMPAGNIE Inventor ADIB LESAUX, Achraf
yeast cell walls that is rich in β-glucans and intended for use in reducing and/or preventing the formation of dental biofilm formation.
3.WO/2026/102046GUM ACACIA-FREE AND WEIGHTING AGENT-FREE EMULSIONS
WO - 15.05.2026
Int.Class A23L 27/00
AHUMAN NECESSITIES
23FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; PREPARATION, TREATMENT OR PRESERVATION THEREOF
LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
27Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
 Appl.No PCT/US2025/054230 Applicant ABSTRAX TECH INC. Inventor OJEDA, Marcos A.
Compositions in the form of an oil-in-water emulsion composition include an oil phase that includes a flavorant, and optionally an emulsifier adjuvant; and a continuous aqueous phase that includes water, an emulsifier adjuvant and an emulsifying agent, wherein the oil-in-water emulsion composition is substantially free of weighting agents and gum acacia.
4.WO/2026/097620USE OF GANODERMA LUCIDUM SPORE OIL IN INHIBITING OCCURRENCE AND DEVELOPMENT OF TUMORS
WO - 15.05.2026
Int.Class A61K 36/074
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
06Fungi, e.g. yeasts
07Basidiomycota, e.g. Cryptococcus
074Ganoderma
 Appl.No PCT/CN2024/133403 Applicant GUANGZHOU HANFANG PHARMACEUTICAL CO.,LTD. Inventor LIU, Juyan
A use of ganoderma lucidum spore oil in inhibiting occurrence and development of tumors. The ganoderma lucidum spore oil has the effect of improving tumor susceptibility mediated by emotional stress in mice, can also reduce emotional stress in tumor patients, has good safety, and can be used for preparing a drug for inhibiting the occurrence and development of tumors.
5.WO/2026/101880COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES OR DISORDERS IN MAMMALIAN ANIMALS
WO - 15.05.2026
Int.Class A61K 36/07
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
06Fungi, e.g. yeasts
07Basidiomycota, e.g. Cryptococcus
 Appl.No PCT/US2025/053918 Applicant GEROSYNTH LABORATORIES, INC. Inventor O’DELL, Alisha S.
Pharmaceutical compositions, and methods of production and use for the treatment of neoplastic disease in a mammalian animal. When administered to an animal, the pharmaceutical compositions are useful for the treatment of neoplastic diseases such as various cancers, particularly those affecting mammalian animals such as companion animals.
6.WO/2026/099314COMPOSITION COMPRISING AN EXTRACT OF RHODIOLA ROSEA, TRYPTOPHAN AND VITAMIN K FOR PREVENTING OR REDUCING HAIR LOSS DUE TO STRESS
WO - 15.05.2026
Int.Class A61K 8/35
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
8Cosmetics or similar toiletry preparations
18characterised by the composition
30containing organic compounds
33containing oxygen
35Ketones, e.g. quinones, benzophenone
 Appl.No PCT/EP2025/082054 Applicant GIULIANI S.P.A. Inventor GIULIANI, Giammaria
The invention relates to a cosmetic and/or pharmaceutical composition for preventing or reducing hair loss of a mammal due to stress and for use in the treatment of a hair growth disease or hair growth disorder exacerbated by stress.
7.WO/2026/097619USE OF REISHI SPORE OIL FOR PREVENTING AND TREATING PULMONARY NODULES
WO - 15.05.2026
Int.Class A61K 36/074
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
06Fungi, e.g. yeasts
07Basidiomycota, e.g. Cryptococcus
074Ganoderma
 Appl.No PCT/CN2024/133398 Applicant GUANGZHOU HANFANG PHARMACEUTICAL CO., LTD. Inventor LIU, Juyan
Disclosed is use of reishi spore oil in the preparation of a drug for preventing and treating nodular diseases. Animal experiments show that reishi spore oil has the effect of significantly inhibiting the formation and development of benign granulomatous nodules in the lungs of mice, and also possesses good safety. The reishi spore oil can be used for preparing a drug for preventing and treating the formation and development of pulmonary nodules. The reishi spore oil comprises one or more components of triglyceride, ergosterol, and vitamin E; and the reishi polysaccharide ingredient is not detected.
8.WO/2026/100723ORAL COMPOSITION FOR ANIMAL
WO - 15.05.2026
Int.Class A23L 33/105
AHUMAN NECESSITIES
23FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; PREPARATION, TREATMENT OR PRESERVATION THEREOF
LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
33Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
10using additives
105Plant extracts, their artificial duplicates or their derivatives
 Appl.No PCT/JP2025/039248 Applicant HOKKAIDO GREEN PHARMA CORPORATION Inventor ITO Akira
The purpose of the present disclosure is to provide an oral composition for animals that can improve the oral environment of animals.　The present disclosure relates to: an oral composition for animals that contains Pleurotus citrinopileatus and a plant of the genus Sasa; the oral composition for animals according to claim 1, wherein the Pleurotus citrinopileatus is an extract of Pleurotus citrinopileatus; the oral composition for animals according to claim 1, wherein the plant of the genus Sasa includes Sasa senanensis (Franch. et Sav.) Rehder and/or Sasa kurilensis (Rupr.) Makino; and the oral composition for animals according to claim 1, wherein the plant of the genus Sasa is an extract of a plant of the genus Sasa.
9.WO/2026/097618METHOD FOR ESTABLISHING MODEL FOR CANCER-RELATED FATIGUE CAUSED BY ANTIMETABOLITE CHEMOTHERAPY DRUG
WO - 15.05.2026
Int.Class A61K 49/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
49Preparations for testing in vivo
 Appl.No PCT/CN2024/133395 Applicant GUANGZHOU HANFANG PHARMACEUTICAL CO.,LTD. Inventor LIU, Juyan
A method for establishing a model for cancer-related fatigue caused by an antimetabolite chemotherapy drug. The establishment method comprises pre-administering an oil vehicle to a laboratory animal 15-20 days prior to modeling, wherein the oil vehicle comprises one or more of soybean oil, corn oil, olive oil and sesame oil, and the modeling comprises administering an antimetabolite chemotherapy drug to the laboratory animal. The model has a high success rate, overcomes the defects in existing methods of being prone to causing animal death and difficulty in obtaining sufficient valid data, can effectively reflect cancer-related fatigue caused by clinical use of antimetabolite chemotherapy drugs, and can be used for screening and evaluating anti-cancer-related fatigue drugs.
10.WO/2026/099189YEAST PRODUCT FOR REDUCING OR PREVENTING THE FORMATION OF DENTAL BIOFILM
WO - 15.05.2026
Int.Class A61K 36/064
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
06Fungi, e.g. yeasts
062Ascomycota
064Saccharomycetales, e.g. baker's yeast
 Appl.No PCT/EP2025/081805 Applicant LESAFFRE ET COMPAGNIE Inventor ADIB LESAUX, Achraf
The present invention relates to the field of oral/dental hygiene and health. The invention relates to a yeast product used for preventing and/or reducing the formation of dental biofilm, particularly in dogs.
# -